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Background: Prescribing is said to be irrational if it does not conform to good standards of treatment. Irrational 
prescribing leads to increased cost of drug therapy, increased risk for adverse drug reactions and emergence of drug 
resistance.  
Objective: The study objective was to determine the quality and patterns of prescribing in Makueni County Referral 
Hospital, Kenya, using World Health Organization prescribing indicators.  
Methodology: The design was a descriptive retrospective cross-sectional study. Data was abstracted from 824 
patient encounters selected through quasi-random sampling. Data was collected from the sampled prescriptions using 
a pre-tested data collection form, entered into and analyzed using Stata version 10.0 software.  
Results: The mean number of drugs per patient encounter was 2.7. Only 45.5% of the total drugs were prescribed 
using generic names. Antibiotics and injections were prescribed in 74% and 13.2% of the prescriptions surveyed 
respectively.  
Discussion: On average, inpatients received a higher number of drugs per encounter compared to outpatients, 
probably because they usually have more severe disease than outpatients which may require management with more 
drugs.  
Conclusion: The results showed a trend towards irrational prescribing, particularly polypharmacy, underuse of 
generic names and over-prescription of antibiotics. Relevant educational, managerial and regulatory interventions are 
recommended to remedy the problems.  
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1. Introduction 
Medicines are important weapons in the fight against 
diseases. However, these medicines are ‘double-edged 
swords’ and therefore, they should be used rationally. 
According to the World Health Organization (WHO), 
statistics indicate that more than half of all drugs are 
prescribed, dispensed, or sold improperly across the 
globe, and 50% of patients fail to take them correctly 
(WHO, 2002). Irrational drug use is therefore an 
enormous problem with several undesirable 
consequences such as increased cost of drug therapy, 
increased risk for adverse drug reactions, emergence of 
drug resistance, wastage of resources and reduction in 
the quality of drug therapy (Bhartiy et al, 2008).  
Prescribing is a crucial step in the drug use cycle. 
Prescribing should be rational in order to benefit the 
patient. However, various forms of irrational 
prescribing still exist in many healthcare facilities. The 
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problem includes prescribing using proprietary brand 
names, polypharmacy, over-prescription of antibiotics 
and overuse of injections among other practices. 
Irrational prescribing habits lead to higher treatment 
costs, ineffective therapy, unsafe treatment and 
exacerbation of illness (Desalegn, 2013).  
It is advisable to describe and quantify the current 
situation before mechanisms are put in place to 
promote rational drug use. Prescription surveys using 
WHO prescribing indicators have been employed to 
describe prescribing patterns in healthcare facilities. 
These indicators have been accepted globally and have 
been used in over thirty developing countries (Laing et 
al, 2001). Prescribing practices should be evaluated 
periodically so as to provide feedback to prescribers 
and remedy any problems identified.  
Patterns of prescribing practices have not been studied 
extensively in Kenya hence there is limited data on the 
extent of irrational prescribing in healthcare facilities in 
the country. From the literature reviewed, no drug 
prescribing survey had been conducted before in 
Makueni County Referral Hospital. The hospital was not 
included in the national survey on access to essential 
medicines in Kenya (Ministry of Health, Kenya, 2009), 
neither was it included in the baseline survey to assess 
the pharmaceutical situation in Kenya (Ministry of 
Health, Kenya, 2003). It was therefore an appropriate 
site for the study. This study was conducted in order to 
assess the quality and patterns of drug prescribing 
practices in Makueni County Referral Hospital. 
2. Methodology 
2.1 Study setting 
The study was carried out in Makueni County Referral 
Hospital, the largest hospital in Makueni County. The 
hospital is located in Wote town, about 140 kilometers 
from the country’s capital city, Nairobi.  
2.2 Study design and study population 
The design was a descriptive retrospective hospital-
based cross-sectional study. The study population 
included all patient encounters from outpatient and 
inpatient departments written between 1st January and 
31st December 2013.  
2.3 Sampling and eligibility criteria 
The sampling unit was a patient 
encounter/prescription. According to the WHO, at least 
600 patient encounters should be included in a cross-
sectional study to describe the current prescribing 
practices in one facility, with a greater number, if 
possible (WHO, 1993). Based on this WHO criteria and 
to cater for any excluded prescriptions and also to 
increase the power of the study, a total of 960 patient 
encounters were sampled.  
Quasi-random sampling was employed to get a sample 
size of 960 encounters.  Patient encounters were 
included in the study if they were written between 1st 
January and 31st December 2013 and if they were from 
Makueni County Referral Hospital.  
Out of the 960 encounters sampled, only 824 met the 
eligibility criteria and were therefore included in the 
study. Illegible patient encounters, those from 
comprehensive care clinic and those written before 1st 
January 2013 or after 31st December 2013 were all 
excluded. Prescriptions from the from comprehensive 
care clinic were excluded as they have standard number 
of drugs prescribed as per the current Anti-Retroviral 
Treatment (ART) guidelines. Moreover, these drugs are 
usually prescribed using the approved abbreviations 
instead of the international non-proprietary names. 
2.4 Data collection 
A pre-tested data abstraction form was used to collect 
the relevant data on prescribing indicators, patient 
demographics, disease and prescriber information. Data 
was abstracted retrospectively from stored copies of 
prescriptions, patient files, registers, cards and 
computerized patient records. 
2.5 Outcomes of interest 
Irrational prescribing was measured using the WHO 
prescribing indicators. The primary outcome of interest 
was prevalence of polypharmacy. Polypharmacy 
involves prescribing many/multiple drugs for a patient 
during a specific patient encounter. In this study, 
polypharmacy was defined as prescription of more than 
two drugs per encounter. A cut off of two drugs was 
used because the Kenyan reference value (Ministry of 
Health, Kenya, 2009) for average number of drugs 
prescribed per patient encounter is < 2.  
Secondary outcomes included prevalence of prescribing 
using generic names, prevalence of antibiotic 
prescribing, prevalence of injection prescribing and 
compliance with essential drug list when prescribing. 
Predictor variables were patient sex, patient age, 
patient residence, comorbidities, chronic conditions, 
prescriber sex and prescriber cadre.  
2.6 Statistical analysis 
All filled up data collection instruments were stored 
securely. Data was coded to ensure confidentiality and 
blind the data analyst. Stata software, version 10.0 
(Stata Corp LP, Texas, USA) was used for data analysis.  
All variables were subjected to descriptive data 
analysis. Continuous variables that were normally 
distributed were expressed as mean and standard 
deviation (SD) of the mean. For those continuous 
variables that were not normally distributed, the 
median and interquartile range (IQR) was reported. 
Categorical variables were reported as proportions and 
their corresponding 95% confidence intervals (95% CI). 
Bivariable analysis was done to show the distribution of 
the outcome of interest across the different arms of the 
predictor variables. Inferential methods such as the Chi 
Square test and Mann-Whitney test were used in the 
bivariable analysis.  
Logistic regression modelling was conducted to 
determine the most important risk factors for 
polypharmacy and to control for confounding. Both 
bivariable and multivariable analyses were conducted. 
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Model building was done using a manual stepwise 
forward approach to achieve the parsimonious model. 
The results of the logistic regression analysis were 
reported using odds ratios (OR).   
For all analyses, p values less than 0.05% were 
considered statistically significant. 
2.7 Ethical considerations 
The study was approved by the Kenyatta National 
Hospital and University of Nairobi Ethics and Research 
Committee (KNH/UON ERC, Approval Reference No. 
KNH-ERC/A/82 (P9/01/2014). 
3.  Results and Discussion 
3.1 Baseline characteristics  
A total of 824 participants were included in the study, 
out of which 720 were from outpatient and 104 from 
inpatient department. The baseline characteristics of 
the participants are summarized in Table 1. Majority of 
the study participants were females (53.9%). The 
median age for the participants was 29 [IQR: 15 – 43] 
years. The age ranged from 0.1 to 95 years. Most of the 
patients were rural dwellers (78.5%). This was 
expected since the hospital is situated in a rural county.  
  
Table 1: Baseline characteristics of study participants 
Baseline characteristic 
Outpatient 
(N=720) 
Inpatient 
(N=104) 
Total 
(N=824) 
p value* 
Patient demographics:     
Sex:     
    Male  331 (46%) 49 (47.1%) 380 (46.1%) 0.827** 
    Female 389 (54%) 55 (52.9%) 444 (53.9%)  
Age in years, Median [IQR] 30 [15 – 43] 24 [6.5 – 45] 29 [15 – 43] 0.155*** 
Residence:     
    Town/Market 160 (22.2%) 17 (16.4%) 177 (21.5%) 0.173** 
    Village/Rural 560 (77.8%) 87 (83.7%) 647 (78.5%)  
Disease information:     
Comorbidities:     
    Yes 149 (20.7%) 22 (21.2%) 171 (20.8%) 0.914** 
    No 571 (79.3%) 82 (78.9%) 653 (79.3%)  
Chronic conditions:     
    Yes 93 (12.9%) 22 (21.2%) 115 (14%) 0.023** 
    No 627 (87.1%) 82 (78.9%) 709 (86%)  
Length of hospital admission in 
days, Mean (SD) 
- 5.96 (4.24) - - 
Prescriber characteristics:     
Sex:     
    Male  469 (65.1%) 69 (66.4%) 538 (65.3%) 0.809** 
    Female  251 (34.9%) 35 (33.7%) 286 (34.7%)  
Cadre:     
    Clinical Officers 507 (70.4%) 13 (12.5%) 520 (63.1%)  
    Medical Practitioners 167 (23.2%) 83 (79.8%) 250 (30.3%) < 0.001** 
    Others (nurses & dental 
officers) 
46 (6.4%) 8 (7.7%) 54 (6.6%) < 0.001** 
*Significant p values are bolded, **Pearson Chi-square test, ***Mann-Whitney test 
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Table 2: Prescribing indicators 
Indicator, 
Outpatient 
(N=720) 
Inpatient 
(N=104) 
Total 
(N=824) 
Reference 
values 
(KENYA)a 
Standard 
values 
(WHO)b 
p value* 
Average number of drugs 
per encounter, (SD) 
2.48 (1.34) 4.18 (1.99) 2.70 (1.54) < 2 1.6 – 1.9 <0.001*** 
Percentage of drugs 
prescribed by generic 
name (95% CI) 
45 
(40.9-48.3) 
47.6 
(43.5-51.7) 
45.5 
(41.2-49.6) 
100 100 0.095** 
Percentage of encounters 
with an antibiotic 
prescribed (95% CI) 
72.9 
(69.7-76.2) 
81.7 
(74.2-89.3) 
74 
(72-77) 
< 30 20 – 26.8 0.055** 
Percentage of encounters 
with an injection 
prescribed (95% CI) 
1.5 
(0.6-2.4) 
94.2 
(89.7-98.8) 
13.2 
(10.9-15.6) 
< 20 13.4 – 24.1 <0.001** 
Percentage of drugs 
prescribed from essential 
drugs list or formulary 
(95% CI) 
90.6 
(84.8-95.4) 
82.8 
(77.5-87.7) 
89.1 
(84.4-94.3) 
100 100 0.098** 
*Significant p values are bolded, **Pearson Chi-square test, ***Mann-Whitney test, a=Adapted from “Access to Essential Medicines in 
Kenya. A Health Facility Survey” (Ministry of Health, Kenya, 2009), b=Adapted from “The development of standard values for the WHO 
drug use prescribing indicators,” (Isah et al, 2008). 
About a fifth of the study participants had comorbidities 
(20.8%). Chronic conditions were present in 14% of the 
participants. These chronic conditions were 
significantly more prevalent among inpatients (21.2%) 
compared to outpatients (12.9%), p = 0.023. The 
median length of hospitalization for inpatients was 5 
[IQR: 3 – 8] days.  
Clinical officers generated most of the prescriptions 
(63.1%). However, comparing the two clinical settings, 
medical practitioners generated a majority of the 
prescriptions for inpatients (79.8%) whereas clinical 
officers generated the highest percentage of 
prescriptions for outpatients (70.4%), p < 0.001. This 
could be due to the fact that clinical officers are the first 
line clinicians in most public hospitals in Kenya; hence 
they form a bigger percentage of prescribers in 
outpatient. On the other hand, medical practitioners 
usually deal with more complex medical conditions that 
require hospital admissions.  
3.2 Prescribing indicators 
3.2.1 Number of drugs per encounter 
The mean number of drugs prescribed per encounter 
was 2.7 (SD: 1.54) (Table 2). This mean was higher 
compared to the country’s reference value of less than 2 
and the WHO standard value (1.6 – 1.9). This indicated 
some degree of polypharmacy. Inpatients (4.18) 
received significantly a higher average number of drugs 
per encounter compared to outpatients (2.48), p < 
0.001. Two or more drugs were prescribed in 83.7% of 
all inpatient prescriptions compared to 45.7% of 
outpatient prescriptions. Only two (0.3%) outpatient 
prescriptions had 7 to 8 drugs prescribed compared to 
23 (22.1%) inpatient prescriptions (Table 3). This 
indicated a higher degree of polypharmacy in inpatient 
compared to outpatient department. This could be 
explained by the fact that inpatients usually have severe 
disease than outpatients which may require more drugs 
in order to manage successfully. The higher inpatient 
average compared to outpatient was consistent with 
results obtained from prescription surveys conducted in 
Pakistan (Najmi et al, 1998) and Nigeria (Chukwuani et 
al, 2002). 
Table 3: Number of drugs prescribed per patient 
encounter 
No. of 
drugs 
prescribed 
Outpatient Inpatient Total 
1 220 (30.6%) 12 (11.5%) 232 (28.2%) 
2 171 (23.8%) 5 (4.8%) 176 (21.4%) 
3 170 (23.6%) 25 (24%) 195 (23.7%) 
4 91 (12.6%) 26 (25%) 117 (14.2%) 
5 60 (8.3%) 9 (8.7%) 69 (8.4%) 
6 6 (0.8%) 4 (3.9%) 10 (1.2%) 
7 1 (0.1%) 19 (18.3%) 20 (2.4%) 
8 1 (0.1%) 4 (3.9%) 5 (0.6%) 
Total 720 (100%) 104 (100%) 824 (100%) 
 
The mean number of drugs prescribed per encounter 
for outpatients (2.48) was similar to that reported by 
surveys done in Saudi Arabia (El Mahalli, 2012) and 
China (Li et al., 2012). This average was lower 
compared to that reported by surveys conducted in 
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Kenya (Ministry of Health, Kenya, 2009) and 
Bangladesh (Afsan et al., 2013). Compared to the study 
results, lower averages have been reported by studies 
done in Lebanon (Hamadeh et al, 2001) and Sudan 
(Hogerzeil et al., 1993). Inadequate training and 
financial incentives to prescribers by drug industry 
have been documented as major contributors to 
polypharmacy. 
3.2.2 Drugs prescribed by generic name  
Prescribing using international non-proprietary 
(generic) names was not widely practiced in the 
hospital. Less than half (45.5%) of all drugs were 
prescribed using generic names. Prescribing using 
generic names was slightly higher in inpatient (47.6%) 
compared to outpatient (45%) department, though the 
difference was not statistically significant, p = 0.095 
(Table 2).  
Prescribing using proprietary brand names was very 
common with combination drugs such as 
ophthalmological preparations and cardiovascular 
agents. This may be attributed to the lengthy generic 
names of such combinations. Other reasons that might 
have contributed to the low prevalence of prescribing 
using generic names include prescribers’ perception 
that most generics are of poor quality or less effective 
compared to branded drugs and drug promotion by 
medical representatives.  
The percentage of drugs prescribed using generic name 
was very low compared to the country’s reference value 
and the WHO standard value of 100%. These results 
were similar to those reported by studies done in Kenya 
(Ministry of Health, Kenya, 2003) and India (Bhartiy et 
al., 2008). Lower percentages of generic prescribing 
were reported by studies conducted in Kenya (Ministry 
of Health, Kenya, 2009) and Bangladesh (Afsan et al., 
2013). Compared to our results, higher prevalence of 
generic prescribing was reported by studies conducted 
in Ghana (Bosu and Ofori-Adjei, 2000) and Ethiopia 
(Desalegn, 2013). 
3.2.3 Encounters with an antibiotic prescribed  
The prevalence of antibiotic prescribing was very high 
(74%). The prevalence was higher for inpatients 
(81.7%) compared to outpatients (72.9%), though the 
difference was not statistically significant, p = 0.055. 
This may be explained by the fact that inpatients usually 
have severe disease than outpatients which may require 
empirical treatment with antibiotics even before 
confirmatory diagnosis. Overestimation of the disease 
severity could also have led to over-prescription of 
antibiotics. The higher inpatient prevalence was 
consistent with results obtained from a survey done in 
Nigeria (Chukwuani et al., 2002) which reported a 
prevalence of 96.7% for inpatients compared to 50.3% 
for outpatients.  
The prevalence of antibiotic prescribing in outpatient 
department (72.9%) was very high compared to the 
country’s reference value of less than 30% and the 
standard value derived by WHO to serve as ideal (20 - 
26.8%). This indicated over-prescription of antibiotics. 
The results were similar compared to those of surveys 
conducted in Kenya (Ministry of Health, Kenya, 2003; 
Ministry of Health, Kenya, 2009). Over-prescription of 
antibiotics has also been documented by studies done in 
Nigeria (Erah et al, 2003) and Iran (Ghadimi et al., 
2011). 
In encounters where an antibiotic was prescribed, 82% 
of the prescriptions had one antibiotic, 15.5% had two 
antibiotics and 2.5% had three or more antibiotics. 
Prescriptions with three or more antibiotics were 
almost exclusively prescribed for inpatients (99.5%). 
The commonly prescribed antibiotics differed between 
outpatients and inpatients. In the outpatient 
department, the top four commonly prescribed 
antibiotics were amoxicillin (47.6%), cotrimoxazole 
(23.2%), ciprofloxacin (13.1%) and flucloxacillin 
(10.5%). The top four commonly prescribed antibiotics 
for inpatients were benzyl penicillin (52.9%), 
gentamicin (45.9%), ceftriaxone (37.7%) and 
chloramphenicol (17.7%). Most inpatient prescriptions 
had injectable antibiotics as opposed to oral 
formulations, while most outpatient prescriptions had 
oral antibiotics.  
3.2.4 Encounters with an injection prescribed  
Injections were prescribed in 13.2% of all prescriptions 
surveyed. The prevalence of injection prescribing was 
very low for outpatients (1.5%) and extremely high for 
inpatients (94.2%), (p<0.001). The higher inpatient 
prevalence was consistent with results from a survey 
done in Pakistan (Najmi et al., 1998). This could be 
explained by the severity of illness which is higher for 
inpatients compared to outpatients. Injections are 
preferred for severely ill patients since they have a 
faster onset of action and also severely ill patients may 
be unable to take drugs orally. 
The prevalence of injection prescribing in outpatient 
department (1.5%) was within the country’s reference 
value of less than 20% and lower than the standard 
value derived by WHO to serve as ideal (13.4% - 
24.1%). These results were comparable to those of a 
study conducted in India (Karande et al, 2005). Other 
studies that have reported acceptable percentage of 
injection prescribing, though higher than our findings 
include surveys done in Kenya (Ministry of Health, 
Kenya, 2009) and Bangladesh (Afsan et al., 2013). Over-
prescription of injections has been documented by 
studies conducted in China (Li et al., 2012) and Ethiopia 
(Desalegn, 2013).  
In prescriptions where an injection was prescribed, 
most (90%) had two or more injections prescribed. 
Outpatient prescriptions accounted for almost all 
(98.2%) prescriptions with one injection prescribed. 
Diclofenac (65.6%) was the most frequently prescribed 
injection in outpatient department followed by insulin 
(29.5%) and hydrocortisone (25.2%) injection. In the 
inpatient department, benzyl penicillin (55.7%) was the 
most frequently prescribed injection followed by 
gentamicin (48.2%) and ceftriaxone (40.3%) injection. 
3.2.5 Drugs prescribed from the Kenya Essential 
Medicines List (KEML) 
Most (89.1%) of the drugs were prescribed from the 
Kenya Essential Medicines List (KEML), indicating a 
high compliance with KEML during prescribing. This 
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could be attributed to the availability of copies of KEML 
in the facility. Compliance was higher in outpatient 
(90.6%) compared to inpatient (82.8%) department, 
though the difference was not statistically significant, p 
= 0.098. Drugs that contributed to non-compliance with 
KEML were mostly cough preparations and various 
creams and ointments.  
The percentage of drugs prescribed from the KEML in 
outpatient department (90.6%) was encouraging but 
below the country’s and WHO’s reference values of 
100%. The results were consistent with those reported 
by studies conducted in Kenya (Ministry of Health, 
Kenya, 2009) and Uganda (Bell et al, 2010). On the 
contrary, surveys conducted in Bangladesh (Afsan et al, 
2013) and China (Dong et al, 2011) reported low 
compliance compared to our results. 
3.3 Completeness of prescriptions 
The overall percentage of complete prescriptions was 
low (46%). The percentage of complete prescriptions 
was 41.7 and 100% for outpatient and inpatient 
prescriptions respectively. Most of the incomplete 
prescriptions lacked diagnosis. The low percentage of 
complete prescriptions at outpatient department could 
be attributed to the frequent stock out of the standard 
printed prescription books. This led to improvising of 
prescription books using plain papers which did not 
have the various sections required to be filled when 
writing prescriptions. 
3.4 Factors associated with polypharmacy 
A positive correlation was found between patient age 
and number of drugs prescribed whereby the number 
of drugs prescribed seemed to increase with increasing 
patient age (Figure 1). However this correlation was 
weak with a correlation coefficient of 0.36. A similar 
correlation was reported in a study done at Kitovu 
Hospital in Uganda (Bell et al, 2010). 
Logistic regression modelling was used to determine 
the most important factors associated with 
polypharmacy and to control for confounding (Table 4). 
Bivariable and multivariable analyses were conducted. 
In the multivariable analysis, polypharmacy was more 
likely to occur in prescriptions of older patients 
compared to those of younger patients. For every one 
year increase in patient age, the odds of polypharmacy 
occurring increased by 2% (adjusted OR 1.02; 95% CI: 
1.01 – 1.03; p < 0.001). This could be explained by the 
fact that older people usually present with several 
diseases together, hence requiring a greater number of 
drugs compared to younger people. Indeed 90% of 
patients aged 60 years or more in the study received 
three or more drugs. Polypharmacy was one and half 
times as likely to be seen in prescriptions for patients 
living in town settings compared to those living in rural 
settings (adjusted OR 1.55; 95% CI: 1.04 – 2.31; p = 
0.030).  
Polypharmacy was 86% less likely to be seen in 
outpatient prescriptions compared to inpatient 
prescriptions (adjusted OR 0.14; 95% CI: 0.07 – 0.26); p 
< 0.001). On the other hand, prescriptions for comorbid 
conditions were 6.3 times more likely to exhibit 
polypharmacy compared to the ones with no 
comorbidities (adjusted OR 6.30; 95% CI: 4.06 – 9.77; p 
< 0.001). This was expected since comorbidities involve 
several diseases which may require different drugs to 
manage hence leading to polypharmacy.  
 
 
Figure 1: Correlation between patient age and number of drugs prescribed per encounter 
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Table 4: Logistic regression analysis of factors associated with polypharmacy 
Predictor variables 
Bivariable analysis Multivariable analysis 
Crude OR (95% CI) p value* Adjusted OR (95% CI) p value* 
Patient demographics:     
Sex: Male  0.91 (0.69 – 1.20) 0.498 0.96 (0.69 – 1.33) 0.797 
Age in years 1.03 (1.02 – 1.03) <0.001 1.02 (1.01 – 1.03) <0.001 
Residence: Town/Market 0.93 (0.67 – 1.30) 0.689 1.55 (1.04 – 2.31) 0.030 
Clinical setting: Outpatient 0.16 (0.10 – 0.28) <0.001 0.14 (0.07 – 0.26) <0.001 
Disease information:     
Presence of comorbidities 4.58 (3.09 – 6.77) <0.001 6.30 (4.06 – 9.77) <0.001 
Presence of chronic conditions 
12.03 (6.35 – 
22.78) 
<0.001 8.08 (3.96 – 16.50) <0.001 
Prescriber characteristics:     
Sex: Male 1.77 (0.60 – 1.17) <0.001 1.35 (0.95 – 1.93) 0.098 
Cadre:     
    Clinical Officers 1.00 (Ref)  1.00 (Ref)  
    Medical Practitioners 3.70 (2.67 – 5.11) <0.001 1.46 (0.95 – 2.26) 0.085 
    Other (nurses & dental officers) 2.40 (13.50 – 4.26) 0.003 1.34 (0.66 – 2.70) 0.419 
*Significant p values are bolded 
The prevalence of polypharmacy in prescriptions for 
chronic conditions was eight-fold that of prescriptions 
for non-chronic conditions (adjusted OR 8.08; 95% CI: 
3.96 – 16.50; p < 0.001). This could possibly be due to 
the observation that most chronic conditions require 
multiple drugs for effective management. In addition, 
most of these chronic conditions usually present with 
additional symptoms which may lead to extra drugs 
being prescribed.   
In the parsimonious model, four predictor variables 
were identified as the most important variables 
associated with polypharmacy. These were patient age, 
clinical setting, comorbid conditions and chronic 
conditions. The odds ratios in the parsimonious model 
were similar to the adjusted odds ratios in the 
multivariable logistic regression. 
4. Conclusion 
The results show a trend towards inappropriate 
prescribing, particularly polypharmacy, underuse of 
generic names and over-prescription of antibiotics. 
Frequent prescription surveys and drug utilization 
studies are recommended to identify irrational 
prescribing. This should be followed by relevant 
educational, managerial and regulatory interventions to 
remedy any problems identified. This being among the 
first few studies on prescribing practices using WHO 
prescribing indicators in Makueni County and Kenya in 
general, further research is required. 
Study limitations 
In the retrospective prescription survey, illegible 
prescriptions were a challenge. All illegible and faded 
prescriptions were excluded from the study. Incomplete 
and missing patient records also posed a challenge. 
These were also excluded. 
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